DoxorubicinAntibiotics, AntineoplasticCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsEtoposideAntineoplastic AgentsVinblastineAntineoplastic Agents, PhytogenicP-GlycoproteinBleomycinLomustineDrug Resistance, MultipleVinca AlkaloidsLeukemia P388Drug Resistance, NeoplasmMethotrexateDaunorubicinDrug ResistanceVincristineCombined Modality TherapyDrug Administration ScheduleRazoxaneAntibodies, Monoclonal, Murine-DerivedLiposomesLymphoma, Non-HodgkinDrug CarriersCisplatinIfosfamideTreatment OutcomeLymphoma, Large B-Cell, DiffuseDisease-Free SurvivalDose-Response Relationship, DrugPaclitaxelRemission InductionVerapamilPrednisoloneSurvival AnalysisCell Line, TumorTumor Cells, CulturedDrug SynergismAsparaginaseMitoxantroneHodgkin DiseaseDrug Screening Assays, AntitumorRhabdomyosarcomaCytarabineDacarbazineSurvival RateCarcinoma, Small CellBreast NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaDexamethasoneCell SurvivalDactinomycinMelphalanPolyethylene GlycolsTeniposidePrednisoneMultidrug Resistance-Associated ProteinsVindesineApoptosisMultiple MyelomaSarcomaNeoplasm StagingInfusions, IntravenousSarcoma, EwingKB CellsTime FactorsLung NeoplasmsOligodendrogliomaChlorambucilLeukemia L1210AnthracyclinesEpirubicinPrognosisPodophyllotoxinChemotherapy, AdjuvantFluorouracilLeukopeniaCatharanthusLeukemia, LymphoidWilms TumorColchicineLymphoma, FollicularCardiotoxinsHydroxyethylrutosideCarmustineNeutropeniaGranulocyte Colony-Stimulating FactorGenes, MDRCyclosporinsNeoplasm Recurrence, LocalMesnaLymphoma, B-CellNeoplasm TransplantationBone NeoplasmsLymphomaDrug Delivery SystemsBrain NeoplasmsOsteosarcoma